Cargando…

Skin Dosimetry with EBT3 Radiochromic Film in Radiotherapy of Parotid Cancer

BACKGROUND: Skin is a sensitive organ and should be spared in radiotherapy and irradiation of skin in radiotherapy can cause to acute and late skin effects such as erythema, desquamation, epilation, color change, or even necrosis. OBJECTIVE: The aim of the present study is to do skin dosimetry in ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Bahreyni Toossi, Mohammad Taghi, Ghorbani, Mahdi, Khorshidi, Farideh, Mohammadi, Mohammad, Mohamadian, Nastaran, Akbari, Fateme, Dayani, Mahdie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shiraz University of Medical Sciences 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546163/
https://www.ncbi.nlm.nih.gov/pubmed/34722402
http://dx.doi.org/10.31661/jbpe.v0i0.1083
_version_ 1784590134450061312
author Bahreyni Toossi, Mohammad Taghi
Ghorbani, Mahdi
Khorshidi, Farideh
Mohammadi, Mohammad
Mohamadian, Nastaran
Akbari, Fateme
Dayani, Mahdie
author_facet Bahreyni Toossi, Mohammad Taghi
Ghorbani, Mahdi
Khorshidi, Farideh
Mohammadi, Mohammad
Mohamadian, Nastaran
Akbari, Fateme
Dayani, Mahdie
author_sort Bahreyni Toossi, Mohammad Taghi
collection PubMed
description BACKGROUND: Skin is a sensitive organ and should be spared in radiotherapy and irradiation of skin in radiotherapy can cause to acute and late skin effects such as erythema, desquamation, epilation, color change, or even necrosis. OBJECTIVE: The aim of the present study is to do skin dosimetry in radiotherapy of parotid cancer using Gafchromic EBT3 radiochromic film. EBT3 radiochromic films were calibrated in 0.2-5 Gy dose range. MATERIAL AND METHODS: This is an experimental study in the field of radiotherapy physics. Treatment planning was performed on a RANDO phantom for treatment of parotid cancer by a clinical oncologist. Based on the treatment planning, the skin dose at various points in the overlapping region of right anterior-oblique and right posterior-oblique fields were measured using EBT3 radiochromic film. RESULTS: The minimum and maximum skin doses in a fraction (with 2.0 Gy prescribed dose) were 0.50 Gy and 0.97 Gy, respectively. Based on these values, the total skin dose in 30 treatment fractions (for removed tumor) or in 35 treatment fractions (for unremoved tumor) was in the range of 15-33 Gy. CONCLUSION: Based on the skin dosimetry results of parotid cancer radiotherapy using EBT3 films, it is predicted that there will occur mild skin reactions and these reactions can be neglected due to being mild.
format Online
Article
Text
id pubmed-8546163
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Shiraz University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-85461632021-10-29 Skin Dosimetry with EBT3 Radiochromic Film in Radiotherapy of Parotid Cancer Bahreyni Toossi, Mohammad Taghi Ghorbani, Mahdi Khorshidi, Farideh Mohammadi, Mohammad Mohamadian, Nastaran Akbari, Fateme Dayani, Mahdie J Biomed Phys Eng Original Article BACKGROUND: Skin is a sensitive organ and should be spared in radiotherapy and irradiation of skin in radiotherapy can cause to acute and late skin effects such as erythema, desquamation, epilation, color change, or even necrosis. OBJECTIVE: The aim of the present study is to do skin dosimetry in radiotherapy of parotid cancer using Gafchromic EBT3 radiochromic film. EBT3 radiochromic films were calibrated in 0.2-5 Gy dose range. MATERIAL AND METHODS: This is an experimental study in the field of radiotherapy physics. Treatment planning was performed on a RANDO phantom for treatment of parotid cancer by a clinical oncologist. Based on the treatment planning, the skin dose at various points in the overlapping region of right anterior-oblique and right posterior-oblique fields were measured using EBT3 radiochromic film. RESULTS: The minimum and maximum skin doses in a fraction (with 2.0 Gy prescribed dose) were 0.50 Gy and 0.97 Gy, respectively. Based on these values, the total skin dose in 30 treatment fractions (for removed tumor) or in 35 treatment fractions (for unremoved tumor) was in the range of 15-33 Gy. CONCLUSION: Based on the skin dosimetry results of parotid cancer radiotherapy using EBT3 films, it is predicted that there will occur mild skin reactions and these reactions can be neglected due to being mild. Shiraz University of Medical Sciences 2021-10-01 /pmc/articles/PMC8546163/ /pubmed/34722402 http://dx.doi.org/10.31661/jbpe.v0i0.1083 Text en Copyright: © Journal of Biomedical Physics and Engineering https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 Unported License, ( http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Bahreyni Toossi, Mohammad Taghi
Ghorbani, Mahdi
Khorshidi, Farideh
Mohammadi, Mohammad
Mohamadian, Nastaran
Akbari, Fateme
Dayani, Mahdie
Skin Dosimetry with EBT3 Radiochromic Film in Radiotherapy of Parotid Cancer
title Skin Dosimetry with EBT3 Radiochromic Film in Radiotherapy of Parotid Cancer
title_full Skin Dosimetry with EBT3 Radiochromic Film in Radiotherapy of Parotid Cancer
title_fullStr Skin Dosimetry with EBT3 Radiochromic Film in Radiotherapy of Parotid Cancer
title_full_unstemmed Skin Dosimetry with EBT3 Radiochromic Film in Radiotherapy of Parotid Cancer
title_short Skin Dosimetry with EBT3 Radiochromic Film in Radiotherapy of Parotid Cancer
title_sort skin dosimetry with ebt3 radiochromic film in radiotherapy of parotid cancer
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546163/
https://www.ncbi.nlm.nih.gov/pubmed/34722402
http://dx.doi.org/10.31661/jbpe.v0i0.1083
work_keys_str_mv AT bahreynitoossimohammadtaghi skindosimetrywithebt3radiochromicfilminradiotherapyofparotidcancer
AT ghorbanimahdi skindosimetrywithebt3radiochromicfilminradiotherapyofparotidcancer
AT khorshidifarideh skindosimetrywithebt3radiochromicfilminradiotherapyofparotidcancer
AT mohammadimohammad skindosimetrywithebt3radiochromicfilminradiotherapyofparotidcancer
AT mohamadiannastaran skindosimetrywithebt3radiochromicfilminradiotherapyofparotidcancer
AT akbarifateme skindosimetrywithebt3radiochromicfilminradiotherapyofparotidcancer
AT dayanimahdie skindosimetrywithebt3radiochromicfilminradiotherapyofparotidcancer